EMA Bidders, An Infographic On The Runners And Riders
Executive Summary
Denmark, France, Ireland, Italy, Spain and Sweden have all have expressed a keen interest in hosting the European Medicines Agency once the UK leaves the EU. Bids are expected to be made sometime early next year, probably once the UK government triggers Article 50. There is at present no formal process for allocating an agency to a particular EU country, as this tends to be done via a process of political wrangling, so each prospective candidate will need to garner as much support for their bid as possible from the other member states.
You may also be interested in...
What Does 2017 Hold For Pharma?
Few would argue that 2016 threw a number of curveballs into the global arena. With the New Year upon us, Scrip took a deep breath and asked a number of internal and external contributors across the pharma and biotech spectrum for their expectations for 2017.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.